Maxillary Sinus Cancer, also known as malignant tumor of the maxillary sinus, is related to head and neck cancer and paranasal sinus cancer, and has symptoms including pain and rhinorrhea. An important gene associated with Maxillary Sinus Cancer is MIR299 (MicroRNA 299). The drugs Pembrolizumab and Cisplatin have been mentioned in the context of this disorder. Affiliated tissues include lymph node and bone.